What they were paid
Arcus Biosciences Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $55,288 | $133,266 | $266,488 | $0 | $455,042 |
| FY2024 | $51,422 | $133,560 | $267,012 | $0 | $451,994 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcus Biosciences, Inc. DEF 14A filed April 21, 2026, accession 0001724521-26-000025, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Arcus Biosciences pays directors a $45,000 cash retainer.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the Arcus Biosciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Perlman, M.D., Ph.D | Independent Director | $472,542 |
| Antoni Ribas, M.D., Ph.D | Independent Director | $521,264 |
| David Lacey, M.D | Independent Director | $563,764 |
| Dietmar Berger, M.D., Ph.D | Director | $0 |
| Johanna Mercier | Director | $0 |
| Kathryn Falberg | Independent Director | $468,834 |
| Linda Higgins, Ph.D | Director | $0 |
| Nicole Lambert | Independent Director | $461,251 |
| Terry Rosen, Ph.D | Chair of the Board | $0 |
| Yasunori Kaneko, M.D | Lead Independent Director | $500,331 |
The full Arcus Biosciences compensation record
free company briefThis page is one director within Arcus Biosciences's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat